InvestorsHub Logo
Followers 0
Posts 1366
Boards Moderated 0
Alias Born 05/19/2018

Re: SamuraiX post# 13911

Friday, 05/25/2018 10:07:01 AM

Friday, May 25, 2018 10:07:01 AM

Post# of 18666
Agreed! In fact, OXS-3550 TriKE has been proven to superior to OXS-1550 in in vivo studies, so I don't expect OXS-1550 to pass Phase II trials, however OXS-3550 TriKE most likely will. As it has been proven to be more effective than Rituxan in killing cancer cells.
PainBrake will use a patented technology - and unique shape - that allows tablets to be easily broken into smaller, precise doses, for maximum dose flexibility and accuracy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News